Dolon is a strategic market access consultancy for life sciences companies wanting to obtain reimbursement for their rare and severe disease medicines.
We take complex data and translate it into simple, evidence-based value propositions for payers and policy makers. Our key service areas include:
• Value Strategy & Communication
• Pricing & Reimbursement
• Market Access Policy
We understand how rare disease policy is evolving, and what payer engagement is necessary to ensure sustainable funding. Our ethos is to work collaboratively with our clients and external stakeholders to ensure that orphan medicines deliver on their promise to patients.